• Voyager Therapeutics outlines gene therapy pipeline. Clinical partnerships frame the next phase AD HOC NEWS Wed, 08 Jul 2026 13:02:27 GMT
• Voyager Therapeutics outlines its gene therapy pipeline. Investors focus on neurology targets AD HOC NEWS Tue, 07 Jul 2026 19:39:10 GMT
• H.C. Wainwright Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $25 Moomoo Mon, 06 Jul 2026 10:33:00 GMT
• h.c. wainwright maintains voyager therapeutics(vygr.us) with buy rating, maintains target price $25 富途牛牛 Fri, 03 Jul 2026 06:55:21 GMT
• cramer to a 23-year-old: buy it, but it might take a ‘lifetime’ to make money AOL.com Thu, 02 Jul 2026 13:33:43 GMT
• Enterprise value to revenue forward of Voyager Therapeutics, Inc. – NASDAQ:VYGR TradingView Wed, 01 Jul 2026 09:19:59 GMT
• Voyager Therapeutics (VYGR) is Amongst the Best Stocks Under $10, With More Than 50% Upside Yahoo Finance Tue, 30 Jun 2026 16:34:42 GMT
• price to sales forward of voyager therapeutics, inc. – fwb:vt6 TradingView Tue, 30 Jun 2026 11:48:57 GMT
• enterprise value to revenue forward of voyager therapeutics, inc. – fwb:vt6 TradingView Tue, 30 Jun 2026 06:31:25 GMT
• price to earnings forward of voyager therapeutics, inc. – nasdaq:vygr TradingView Tue, 30 Jun 2026 04:38:36 GMT
• Voyager to present Alzheimer’s gene therapy data at AAIC Investing.com Mon, 29 Jun 2026 12:48:08 GMT
• Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s GlobeNewswire Mon, 29 Jun 2026 12:01:00 GMT
• voyager therapeutics, inc. actuals & estimates (nasdaq:vygr) TradingView Fri, 26 Jun 2026 12:54:54 GMT
• h.c. wainwright reaffirms their buy rating on voyager therapeutics (vygr) The Globe and Mail Fri, 26 Jun 2026 12:50:17 GMT
• h.c. wainwright maintains voyager therapeutics(vygr.us) with buy rating, maintains target price $25 Moomoo Thu, 25 Jun 2026 07:00:00 GMT
• Voyager Therapeutics Q1 2026 Earnings: EPS Surpasses Estimates Amid Continued Pipeline Development - Margin Compression Risk dars.gov.et Wed, 24 Jun 2026 07:00:00 GMT
• voyager therapeutics inc (vygr) shareholder structure: major shareholders & institutional holdings TradingKey Fri, 19 Jun 2026 01:28:23 GMT
• Voyager Therapeutics Inc (VYGR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Fri, 19 Jun 2026 01:01:48 GMT
• voyager therapeutics inc (vygr) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 15:41:23 GMT
• TD Cowen Maintains Voyager Therapeutics(VYGR.US) With Buy Rating 富途牛牛 Thu, 18 Jun 2026 07:00:00 GMT
• voyager therapeutics, inc. stock 12‑month price target raised to $15.38, implies 325% upside TradingView Thu, 18 Jun 2026 04:20:00 GMT
• voyager therapeutics inc (vygr) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 19:54:25 GMT
• voyager therapeutics inc (vygr) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 19:53:19 GMT
• voyager therapeutics inc (vygr) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 19:52:45 GMT
• voyager therapeutics inc (vygr) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 19:50:30 GMT
• voyager therapeutics, inc. stock 12‑month price target raised to $15.38, implies 325% upside TradingView Wed, 17 Jun 2026 07:00:00 GMT
• voyager therapeutics inc (vygr) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• voyager sets sail for first tau gene therapy after fda clearance Longevity.Technology Tue, 16 Jun 2026 16:51:08 GMT
• voyager therapeutics inc (vygr) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• voyager therapeutics inc (vygr) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• Voyager Therapeutics (VYGR) director awarded 30,000 stock options at $3.43 Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference markets.businessinsider.com Thu, 11 Jun 2026 07:00:00 GMT
• Voyager Therapeutics director granted 30,000 options | VYGR Insider Trading Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Voyager Therapeutics (VYGR) director receives 30,000 stock options grant Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Voyager Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GERAGHTY JAMES A Moomoo Thu, 11 Jun 2026 07:00:00 GMT
• voyager’s ceo joins h.c. wainwright neuro conference fireside chat Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• voyager therapeutics (vygr) grants director glenn pierce 30,000 stock options Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• voyager therapeutics (vygr) grants director 30,000 stock options at $3.43 Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• voyager therapeutics (vygr) director granted 30,000 stock options at $3.43 Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• voyager director granted options for 30,000 shares | vygr insider trading Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• voyager therapeutics (nasdaq: vygr) doubles authorized common stock after 2026 vote Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• Here's Why We're A Bit Worried About Voyager Therapeutics' (NASDAQ:VYGR) Cash Burn Situation Yahoo Finance Tue, 09 Jun 2026 07:00:00 GMT
• H.C. Wainwright Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $25 富途牛牛 Mon, 08 Jun 2026 07:00:00 GMT
• getting alzheimer’s drugs into the brain is hard. now there’s a new trick. Barron's Wed, 03 Jun 2026 07:30:00 GMT
• Voyager’s tau-targeted gene therapy VY-1706 gains IND approval BioWorld News Tue, 02 Jun 2026 07:00:00 GMT
• Guggenheim Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $22 富途牛牛 Tue, 02 Jun 2026 07:00:00 GMT
• voyager therapeutics (vygr) gains fda approval for alzheimer's g GuruFocus Mon, 01 Jun 2026 15:33:45 GMT
• Voyager Receives FDA IND Clearance for VY1706, First Gene GlobeNewswire Mon, 01 Jun 2026 07:00:00 GMT
• Voyager Therapeutics Q1 2026 Earnings: Narrower Loss Surpasses Estimates Amid Pipeline Progress - Short-Term Outlook dars.gov.et Mon, 01 Jun 2026 07:00:00 GMT
• voyager therapeutics receives fda clearance to begin alzheimer’s gene therapy trial Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• voyager gets fda clearance for alzheimer’s gene therapy trial by investing.com Investing.com UK Mon, 01 Jun 2026 07:00:00 GMT
• one-time gene therapy to lower alzheimer’s tau cleared for first human trial Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• fda clears voyager therapeutics (vygr) ind for alzheimer’s gene therapy vy1706 Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• voyager therapeutics announces fda clearance of investigational new drug application for vy1706 for alzheimer's disease marketscreener.com Mon, 01 Jun 2026 07:00:00 GMT
• voyager therapeutics ind cleared for alzheimer’s gene therapy TipRanks Mon, 01 Jun 2026 07:00:00 GMT
• vygr q1 2026 earnings: eps surpasses estimates as company advances gene therapy pipeline - guidance upgrade report dars.gov.et Sun, 31 May 2026 07:00:00 GMT
• voyager therapeutics stock is waking up before a make-or-break tau window Bez Kabli Wed, 27 May 2026 07:00:00 GMT
• h.c. wainwright maintains voyager therapeutics(vygr.us) with buy rating, maintains target price $25 Moomoo Tue, 26 May 2026 10:31:00 GMT
• h.c. wainwright reiterates voyager therapeutics stock rating on pipeline progress Investing.com Tue, 26 May 2026 07:00:00 GMT
• voyager therapeutics stock (us92916u1025): gene therapy player in focus after recent biotech news AD HOC NEWS Thu, 21 May 2026 06:19:58 GMT
• What Voyager Therapeutics Inc (VYGR) Has Gained on Its Therapy Programs Yahoo Finance Wed, 20 May 2026 07:00:00 GMT
• voyager therapeutics presents glp for toxicology data for vy1706 TipRanks Tue, 19 May 2026 21:29:25 GMT
• voyager therapeutics (vygr) accounting officer reports initial share and option holdings Stock Titan Mon, 18 May 2026 07:00:00 GMT
• voyager therapeutics stock (us92916u1025): gene therapy player draws analyst attention after recent AD HOC NEWS Sun, 17 May 2026 07:00:00 GMT
• wedbush maintains voyager therapeutics(vygr.us) with buy rating, maintains target price $8 Moomoo Fri, 15 May 2026 11:44:49 GMT
• voyager therapeutics | 144: notice of proposed sale of securities pursuant to rule 144 Moomoo Fri, 15 May 2026 07:00:00 GMT
• armistice capital (vygr) reports 3.5m shares, 5.87% stake in voyager Stock Titan Fri, 15 May 2026 07:00:00 GMT
• vygr (nasdaq: vygr) affiliate files form 144 to sell 25,000 shares Stock Titan Fri, 15 May 2026 07:00:00 GMT
• ecor1 and oleg nodelman report 0 shares in voyager (nasdaq: vygr) amendment Stock Titan Fri, 15 May 2026 07:00:00 GMT
• voyager therapeutics (nasdaq: vygr) affiliate files to sell 9,406 shares Stock Titan Fri, 15 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: voyager therapeutics (vygr) and climb bio (clym) The Globe and Mail Fri, 15 May 2026 07:00:00 GMT
• biogen advances alzheimer’s tau program despite midphase miss Fierce Biotech Thu, 14 May 2026 07:00:00 GMT
• vygr technical analysis | trend, signals & chart patterns | voyager therapeutics inc (nasdaq:vygr) ChartMill Thu, 14 May 2026 07:00:00 GMT
• voyager presents preclinical data for alzheimer’s gene therapy by investing.com Investing.com India Thu, 14 May 2026 03:33:01 GMT
• voyager therapeutics (vygr) reports positive findings for alzhei GuruFocus Wed, 13 May 2026 18:11:15 GMT
• voyager therapeutics presents glp for toxicology data for vy1706 TipRanks Wed, 13 May 2026 12:54:51 GMT
• voyager therapeutics presents three-month glp toxicology data for vy1706 and provides updates on gene therapy pipeline marketscreener.com Wed, 13 May 2026 10:01:00 GMT
• one-time gene therapy cut alzheimer’s tau up to 64% in monkeys Stock Titan Wed, 13 May 2026 10:01:00 GMT
• Voyager Therapeutics Advances VY1706 Gene Therapy for Alzheimer's Disease with IND Application on Track for Q2 2026 Quiver Quantitative Wed, 13 May 2026 07:00:00 GMT
• voyager asgct late breaker: single iv dose of vy1706 well GlobeNewswire Wed, 13 May 2026 07:00:00 GMT
• voyager therapeutics’ vy1706 gene therapy shows tau reduction in preclinical models; clinical trial expected in 2h 2026 geneonline.com Wed, 13 May 2026 07:00:00 GMT
• voyager presents preclinical data for alzheimer’s gene therapy by investing.com Investing.com Australia Wed, 13 May 2026 07:00:00 GMT
• voyager nears clinical entry with positive alzheimer’s data grafa.com Wed, 13 May 2026 00:00:00 GMT
• vygr technical analysis | trend, signals & chart patterns | voyager therapeutics inc (nasdaq:vygr) ChartMill Tue, 12 May 2026 07:00:00 GMT
• ccorf maintains voyager therapeutics(vygr.us) with buy rating, maintains target price $12 Moomoo Mon, 11 May 2026 15:39:50 GMT
• voyager therapeutics announces cfo resignation and finance leadership changes TipRanks Sat, 09 May 2026 18:25:03 GMT
• voyager therapeutics (nasdaq:vygr) rating lowered to sell at wall street zen MarketBeat Sat, 09 May 2026 07:00:00 GMT
• voyager therapeutics warns of broad risk exposure and uncertain outlook in latest sec filings TipRanks Sat, 09 May 2026 06:11:26 GMT
• voyager therapeutics (vygr) reports q1 loss, misses revenue estimates MSN Fri, 08 May 2026 10:08:05 GMT
• voyager therapeutics stock (us92916u1025): q1 2026 results and pipeline updates drive sentiment AD HOC NEWS Fri, 08 May 2026 07:00:00 GMT
• voyager therapeutics warns of broad risk exposure and uncertain outlook in latest sec filings TipRanks Fri, 08 May 2026 07:00:00 GMT
• wedbush maintains voyager therapeutics(vygr.us) with buy rating, maintains target price $8 Moomoo Fri, 08 May 2026 07:00:00 GMT
• analyst reaffirms buy on voyager therapeutics as strong cash runway and advancing neurology pipeline set up multiple 2026 catalyst... TipRanks Fri, 08 May 2026 04:43:39 GMT
• Voyager Reports First Quarter 2026 Financial and Operating Results GlobeNewswire Thu, 07 May 2026 07:00:00 GMT
• Voyager Therapeutics (VYGR) Reports Q1 Loss, Misses Revenue Estimates Yahoo Finance Thu, 07 May 2026 07:00:00 GMT
• Companies Like Voyager Therapeutics (NASDAQ:VYGR) Could Be Quite Risky simplywall.st Thu, 07 May 2026 07:00:00 GMT
• alzheimer’s gene therapy moves toward human testing as cash lasts into 2028 Stock Titan Thu, 07 May 2026 07:00:00 GMT
• voyager therapeutics (nasdaq: vygr) trims q1 2026 loss, holds $171.7m cash Stock Titan Thu, 07 May 2026 07:00:00 GMT
• voyager therapeutics (nasdaq: vygr) posts q1 2026 loss and advances tau drugs Stock Titan Thu, 07 May 2026 07:00:00 GMT
• voyager therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 07 May 2026 07:00:00 GMT
• voyager therapeutics (nasdaq:vygr) announces quarterly earnings results MarketBeat Thu, 07 May 2026 07:00:00 GMT
• analyst reaffirms buy on voyager therapeutics as strong cash runway and advancing neurology pipeline set up multiple 2026 catalyst... TipRanks Thu, 07 May 2026 07:00:00 GMT
• voyager therapeutics cfo resigns; robin swartz takes financial charge MSN Tue, 05 May 2026 20:34:17 GMT
• voyager therapeutics cfo resigns; robin swartz takes financial charge MSN Mon, 04 May 2026 16:15:23 GMT
• voyager therapeutics inc expected to post a loss of 53 cents a share - earnings preview TradingView Fri, 01 May 2026 07:00:00 GMT
• h.c. wainwright reaffirms their buy rating on voyager therapeutics (vygr) The Globe and Mail Thu, 30 Apr 2026 07:00:00 GMT
• h.c. wainwright maintains voyager therapeutics(vygr.us) with buy rating, maintains target price $25 Moomoo Wed, 29 Apr 2026 07:00:00 GMT
• voyager iv-delivered cns gene therapies featured in multiple presentations at asgct 2026, including late breaker on tau-targeted v... The Manila Times Tue, 28 Apr 2026 07:00:00 GMT
• major share authorization increase on voyager (vygr) 2026 proxy agenda Stock Titan Tue, 28 Apr 2026 07:00:00 GMT
• voyager therapeutics | ars: annual report to security holders Moomoo Tue, 28 Apr 2026 07:00:00 GMT
• voyager therapeutics | def 14a: definitive information statements Moomoo Tue, 28 Apr 2026 07:00:00 GMT
• alzheimer’s gene therapy from voyager lands late-breaker asgct slot Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• vygr forecast, price target & analyst ratings | voyager therapeutics inc (nasdaq:vygr) ChartMill Fri, 24 Apr 2026 07:00:00 GMT
• voyager therapeutics cfo resigns; robin swartz takes financial charge MSN Thu, 23 Apr 2026 22:17:44 GMT
• voyager therapeutics announces cfo resignation and finance leadership changes The Globe and Mail Wed, 22 Apr 2026 07:00:00 GMT
• voyager therapeutics (nasdaq:vygr) share price crosses above fifty day moving average - here's why MarketBeat Wed, 22 Apr 2026 07:00:00 GMT
Voyager Therapeutics, Inc(NASDAQ:VYGR) 
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1b clinical trial for the treatment of Parkinson's ...
Website: http://www.voyagertherapeutics.com
Founded: 2013
Full Time Employees: 185
Sector: Healthcare
Industry: Biotechnology